Boston Harbor Angels is a prominent investment group focusing on high-growth, early-stage startups. They typically invest in angel, seed, and Series A rounds, with occasional participation in Series B and convertible note rounds. Their investments span various sectors, including healthcare, technology, and consumer products, with notable investments ranging from $100,000 to over $24 million.
The firm boasts a diverse portfolio of companies such as Amsel Medical, Astrocyte Pharmaceuticals, and Avaxia Biologics. Key partners include experienced business leaders who bring a wealth of knowledge and industry connections to the table. Boston Harbor Angels is known for its hands-on approach, offering strategic guidance, mentorship, and access to an extensive network to help portfolio companies achieve significant growth.
Boston Harbor Angels - Portfolio Snapshot
Portfolio activity breakdown across disclosed investments and stages
Total Investments73
Current Portfolio Count56
Total Portfolio Exits3
Top Investment Stages
Angel36 (50.7%)
Seed17 (23.9%)
Series A7 (9.9%)
Series B6 (8.5%)
Series Unknown5 (7.0%)
Stage Mix
Angel 51%Seed 24%Series A 10%Series B 8%Series Unknown 7%
Concentration shown as share of disclosed investments by stage.
Boston Harbor Angels - Classification
- Also Known As
- Boston Harbor Angels Inc.
- NAICS
- 520000Finance and Insurance
- 523000Securities, Commodity Contracts, and Other Financial Investments and Related Activities
- 523900Other Financial Investment Activities
- 523990All Other Financial Investment Activities
- 523999Miscellaneous Financial Investment Activities
- SIC
- 6700Holding And Other Investment Offices
- 6790Miscellaneous Investing
- 6799Investors, Not Elsewhere Classified
Show 6 more industry codes
- NAICS
- 525000Funds, Trusts, and Other Financial Vehicles
- 523910Miscellaneous Intermediation
- 523940Portfolio Management and Investment Advice
- SIC
- 6000Depository Institutions
- 6720Investment Offices
- 6722Management Investment Offices, Open-end